Atlas Trials

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Clinical trial NCT00280566 · COMPLETED

Trial details

NCT number
NCT00280566
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar ManiaBipolar Disorder
Start date
2005-12-01
Primary completion
2008-05-01
Enrollment
584

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.